17-beta-hydroxysteroid dehydrogenase deficiency: Difference between revisions

	17-beta-hydroxysteroid dehydrogenase deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Molecular Genetic Studies
Genotyping
X Ray
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
17-beta-hydroxysteroid dehydrogenase deficiency On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency
17-beta-hydroxysteroid dehydrogenase deficiency in the news
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency

	17-beta-hydroxysteroid dehydrogenase deficiency;
OMIM	264300
DiseasesDB	32638

VisualWikitext

Revision as of 15:11, 19 September 2012

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Treatment

Case Studies

Case #1

Template:WikiDoc Sources

@@ Line 18: / Line 18: @@
-'''17-beta-hydroxysteroid dehydrogenase deficiency''' is a rare [[disorder of sexual development]] which can produce impaired [[virilization]] (traditionally termed [[male pseudohermaphroditism]]) of genetically male infants and children and excessive virilization of female adults. It is inherited as an autosomal recessive condition and is one of the few disorders of sexual development that can affect the [[primary sex characteristic|primary]] and/or [[secondary sex characteristic]]s of both [[XX]] and [[XY]] persons.
+==[[17-beta-hydroxysteroid dehydrogenase deficiency overview|Overview]]==
-==Etiology==
+==[[17-beta-hydroxysteroid dehydrogenase deficiency historical perspective|Historical Perspective]]==
-[[17-beta-hydroxysteroid dehydrogenase deficiency]]  type 3 (17βHSD3) is a disorder in testosterone biosynthesis. As a consequence of this disorder, normal male sexual differentiation in impaired as well as [[virilization]]. In the Netherlands, [[17-beta-hydroxysteroid dehydrogenase deficiency]] is estimated to occur 1:147.000 newborns.<ref>{{cite journal |author=Boehmer A et al |title=17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations |journal=J Clin Endocrinol Metab |volume=84 |issue=12 |pages=4713-21 |year=1999 |pmid=10599740}}</ref>
-==Clinical characteristics==
+==[[17-beta-hydroxysteroid dehydrogenase deficiency classification|Classification]]==
--beta-hydroxysteroid dehydrogenase deficiency-3 is clinically characterized by either ambiguous external genitalia or complete female external genitalia at birth; as a consequence of impaired male sexual differentiation in 46,XY individuals. Further investigations on ambiguous genitalia will eventually lead to findings of [[intersexuality]]. Severely impaired [[virilization]] (often complete absence of male sexual differentiation) can lead to development of female external genitalia. These females (!) are often discovered when there is absence of menarche (first menstruation) and when they begin to virilize during puberty (slowly become more like a man; deepening of the voice, acne, male musculature etc). At careful examination, testis can often be found in the inguinal channel.
-==Biochemistry==
+==[[17-beta-hydroxysteroid dehydrogenase deficiency pathophysiology|Pathophysiology]]==
--beta-hydroxysteroid dehydrogenase deficiency-3 is biochemically characterized by decreased levels of testosterone and increased levels of androstenedione as a result of the defect in conversion of androstenedione into testosterone. This leads to clinically important higher ratio of androstenedione to testosterone (A'dion/T) (see figure).
-[[Image:Test biosynth 17BHSD3.jpg|thumb|left|600px| Biochemical effects of 17β-hydroxysteroid deficiency-3 in testosterone biosynthesis. Typically levels of androstenedione are significantly increased, whilst testosterone levels are decreased, leading to male [[undervirilization]].]]
-==Genetics==
+==[[17-beta-hydroxysteroid dehydrogenase deficiency causes|Causes]]==
--beta-hydroxysteroid dehydrogenase deficiency-3 is caused by gene mutations found in the [[17BHSD3]] gene. 17-beta-hydroxysteroid dehydrogenase deficiency-3 is an autosomal recessive disorder.
+==[[17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis|Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases]]==
+==[[17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics|Epidemiology and Demographics]]==
+==[[17-beta-hydroxysteroid dehydrogenase deficiency risk factors|Risk Factors]]==
+==[[17-beta-hydroxysteroid dehydrogenase deficiency screening|Screening]]==
+==[[17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
+==Diagnosis==
+[[17-beta-hydroxysteroid dehydrogenase deficiency staging|Staging]] | [[17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms|History and Symptoms]] | [[17-beta-hydroxysteroid dehydrogenase deficiency physical examination|Physical Examination]] | [[17-beta-hydroxysteroid dehydrogenase deficiency laboratory findings|Laboratory Findings]] | [[17-beta-hydroxysteroid dehydrogenase deficiency chest x ray|Chest X Ray]] | [[17-beta-hydroxysteroid dehydrogenase deficiency CT|CT]] | [[17-beta-hydroxysteroid dehydrogenase deficiency MRI|MRI]] | [[17-beta-hydroxysteroid dehydrogenase deficiency other imaging findings|Other Imaging Findings]] | [[17-beta-hydroxysteroid dehydrogenase deficiency other diagnostic studies|Other Diagnostic Studies]]
+==Treatment==
+[[17-beta-hydroxysteroid dehydrogenase deficiency medical therapy|Medical Therapy]] | [[17-beta-hydroxysteroid dehydrogenase deficiency surgery|Surgery]] | [[17-beta-hydroxysteroid dehydrogenase deficiency primary prevention|Primary Prevention]] | [[17-beta-hydroxysteroid dehydrogenase deficiency secondary prevention|Secondary Prevention]] | [[17-beta-hydroxysteroid dehydrogenase deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[17-beta-hydroxysteroid dehydrogenase deficiency future or investigational therapies|Future or Investigational Therapies]]
+==Case Studies==
+[[17-beta-hydroxysteroid dehydrogenase deficiency case study one|Case #1]]
-==References==
-<references/>
 [[Category:Genetic disorders]]
 [[Category:Endocrinology]]

17-beta-hydroxysteroid dehydrogenase deficiency
OMIM	264300
DiseasesDB	32638

17-beta-hydroxysteroid dehydrogenase deficiency: Difference between revisions

Revision as of 15:11, 19 September 2012

Diagnosis

Treatment

Case Studies

Navigation menu